Amanda K. A. Silva obtained a Pharmacy degree in 2005 at UFRN, Brazil as well as a PhD on Pharmaceutical Technology in 2008 in the domain of gastro-resistant magnetic microcapsules in the same university. She obtained a second PhD in Cellular and Molecular Biology in 2010 at Université d’Evry, France concerning polymer hydrogels for thermo-controlled cell culture in 3D. In 2013, Amanda obtained a tenured CNRS researcher position at Matter and Complex Systems lab in Paris. She works on extracellular vesicle production and engineering for regenerative medicine and anti-tumor therapy, thermoresponsive hydrogels for fistula therapy as well as nanomedicine based on photo-activated therapies. Amanda published 50 papers, she is the inventor of 6 patents and two spin-offs (EverZom and Healfi Therapeutics) were launched based on the research of her team. Amanda is the coordinator of the ExocyTher project funded by an ERC starting grant.